2m 2m 2m 2m 2m 2m 2m
QUOIN PHARMA SP ADS (QNRX)
NASDAQ
$4.40-$0.16 (-3.51%)
Price as of Jun 03, 2026 5:01 PM EDT- $10.2MMarket Cap
- -49.16%1-Year Change
- BiotechnologyIndustry
QUOIN PHARMA SP ADS (QNRX)
$4.40-$0.16 (-3.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 251,590 -48.56% | 489,079 +421.52% | 93,779 N/A | |
Cost of Revenue | 16.3M +70.97% | 9.5M +1.60% | 9.4M +1.30% | 9.3M +52.70% | |
Gross Profit | -16.3M +75.61% | -9.3M +4.36% | -8.9M -3.00% | -9.2M +51.15% | |
Sales and Marketing Expense | 6.5M +9.49% | 5.9M -2.38% | 6.1M -7.81% | 6.6M +46.33% | |
Research and Development Expense | -9.8M +172.10% | -3.6M +8.91% | -3.3M +23.76% | -2.7M +71.01% | |
Depreciation and Amortization Expense | 100,000 0.00% | 100,000 -3.57% | 103,706 -0.32% | 104,043 0.00% | |
Total Operating Expenses | 22.8M +47.39% | 15.5M +0.03% | 15.4M -2.48% | 15.8M +49.98% | |
Operating Profit | -15.8M +76.34% | -9.0M +3.18% | -8.7M -7.41% | -9.4M -56.29% | |
Interest Income | 482,081 N/A | N/A N/A | N/A N/A | 95,745 N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 482,081 N/A | 0 N/A | 0 -100.00% | 95,745 +108.78% | |
Total Nonoperating Income and Expense | 486,061 -14.12% | 565,993 -18.20% | 691,931 +658.95% | -123,792 -99.20% | |
Income before Taxes | -15.8M +76.34% | -9.0M +3.18% | -8.7M -8.05% | -9.4M -55.98% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | 17,521 0.00% | 17,521 N/A | N/A N/A | |
Net Income | -15.8M +76.34% | -9.0M +3.18% | -8.7M -7.41% | -9.4M -56.29% | |
Net Income from Continuing Operations Applicable to Common | -15.8M +76.34% | -9.0M +3.18% | -8.7M -8.05% | -9.4M -55.98% | |
Basic EPS and Net Income | -14.80 +674.87% | -1.91 -80.19% | -9.64 +147.18% | -3.90 +38,900.00% | |
Diluted EPS and Net Income | -14.80 +674.87% | -1.91 -80.19% | -9.64 +147.18% | -3.90 +38,900.00% | |
Basic Weighted Average Shares | 1.1M -77.22% | 4.7M +420.44% | 900,919 -62.80% | 2.4M -99.85% | |
Diluted Weighted Average Shares | 1.1M -77.22% | 4.7M +420.44% | 900,919 -62.80% | 2.4M -99.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.8M +5.37% | 3.6M +50.90% | 2.4M -16.06% | 2.9M -61.77% | |
Short-Term Investments | 14.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 18.7M +417.35% | 3.6M +50.90% | 2.4M -16.06% | 2.9M -61.77% | |
Total Current Assets | 20.0M +34.04% | 14.9M +32.25% | 11.3M -15.59% | 13.4M +57.33% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | 32,583 0.00% | 32,583 -34.83% | 50,000 0.00% | |
Total Assets | 20.4M +29.80% | 15.7M +29.09% | 12.2M -15.83% | 14.5M +54.52% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 600,000 -85.40% | |
Total Current Liabilities | 5.5M +32.67% | 4.2M +16.74% | 3.6M +1.53% | 3.5M +35.23% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 3.5M -43.29% | |
Total Long-Term Liabilities | 1.7M -25.82% | 2.3M -20.52% | 2.9M +682.59% | 373,599 0.00% | |
Total Liabilities | 7.3M +11.78% | 6.5M -0.008% | 6.5M -7.74% | 7.1M -18.95% | |
Retained Earnings | -71.0M +28.65% | -55.2M +19.40% | -46.2M +23.15% | -37.5M +33.65% | |
Total Stockholders Equity | 13.1M +42.54% | 9.2M +62.51% | 5.7M -23.53% | 7.4M +1,027.31% | |
Total Shares Outstanding | 52.4M +486.06% | 8.9M +806.40% | 987,220 -100.00% | 24.2B +622.37% | |
Cash Flow | |||||
Cash from Operating Activities | -13.5M +72.34% | -7.9M -0.09% | -7.9M -7.27% | -8.5M +48.26% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -4.3M +126.54% | -1.9M -186.29% | 2.2M +121.56% | -10.1M +1,523.86% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 18.0M +64.25% | 11.0M +110.24% | 5.2M -62.76% | 14.0M +3.73% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -3,687.30% +102.87% | -1,817.58% -81.40% | -9,771.83% N/A | |
Operating Margin | N/A N/A | -3,562.33% +100.57% | -1,776.11% -82.25% | -10,003.83% N/A | |
Return on Assets | -87.56% +36.18% | -64.30% -1.45% | -65.25% -17.19% | -78.79% -46.89% | |
Return on Equity | -141.59% +17.45% | -120.55% -9.30% | -132.92% -42.88% | -232.68% -15.24% | |
Revenue Growth | N/A N/A | -48.56% -111.52% | 421.52% N/A | N/A N/A | |
Current Ratio | 3.61 +1.03% | 3.57 +13.29% | 3.15 -16.86% | 3.79 +16.35% | |
Cash Ratio | 0.69 -20.57% | 0.87 +29.27% | 0.67 -17.33% | 0.81 -71.73% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.56 -96.46% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.29 -74.15% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow